Discover open access scientific publications

Search, annotate, share and cite publications

Publications by W Horsnell

A Pantothenate Suxotroph of BCG Rxpressing Gag Confers Enhanced HIV-specific Immunogenicity Compared to Wildtype and Perfingolysin Expressing Strains

Retrovirology

Virology

Infectious Diseases

2012

English

Related publications

Recombinant BCG Overexpressing phoP-phoR Confers Enhanced Protection Against Tuberculosis

English

Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use as a Novel HIV-1 Vaccine

Frontiers in Immunology

Allergy

Immunology

2018

English

Randomised, Placebo-Controlled, Phase I/IIa Evaluation of the Safety and Immunogenicity of Fowlpox Virus Expressing HIV Gag-Pol and Interferon-? In HIV-1 Infected Subjects

Human Vaccines

2005

English

Nef Modulates the Immunogenicity of Gag Encoded in a Non-Infectious HIV DNA Vaccine

English

Specific Inter-Domain Interactions Stabilize a Compact HIV-1 Gag Conformation

PLoS ONE

Multidisciplinary

2019

English

Safety and Immunogenicity of a Gag-Pol Candidate HIV-1 DNA Vaccine Administered by a Needle-Free Device in HIV-1-Seronegative Subjects

Journal of Acquired Immune Deficiency Syndromes

Infectious Diseases

Pharmacology

2007

English

Enhanced Immunogenicity to Mycobacterium Tuberculosis by Vaccination With an Alphavirus Plasmid Replicon Expressing Antigen 85A

Infection and Immunity

English

Immunogenicity and Protective Efficacy Against Murine Tuberculosis of a Prime-Boost Regimen With BCG and a DNA Vaccine Expressing ESAT-6 and Ag85A Fusion Protein

Clinical and Developmental Immunology

2011

English

492. An Enhanced DC-Targeting Lentivector Vaccine to HIV-1 Gag by PD-1 Blockade

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by W Horsnell

A Pantothenate Suxotroph of BCG Rxpressing Gag Confers Enhanced HIV-specific Immunogenicity Compared to Wildtype and Perfingolysin Expressing Strains

Related publications

Recombinant BCG Overexpressing phoP-phoR Confers Enhanced Protection Against Tuberculosis

Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use as a Novel HIV-1 Vaccine

Randomised, Placebo-Controlled, Phase I/IIa Evaluation of the Safety and Immunogenicity of Fowlpox Virus Expressing HIV Gag-Pol and Interferon-? In HIV-1 Infected Subjects

Nef Modulates the Immunogenicity of Gag Encoded in a Non-Infectious HIV DNA Vaccine

Specific Inter-Domain Interactions Stabilize a Compact HIV-1 Gag Conformation

Safety and Immunogenicity of a Gag-Pol Candidate HIV-1 DNA Vaccine Administered by a Needle-Free Device in HIV-1-Seronegative Subjects

Enhanced Immunogenicity to Mycobacterium Tuberculosis by Vaccination With an Alphavirus Plasmid Replicon Expressing Antigen 85A

Immunogenicity and Protective Efficacy Against Murine Tuberculosis of a Prime-Boost Regimen With BCG and a DNA Vaccine Expressing ESAT-6 and Ag85A Fusion Protein

492. An Enhanced DC-Targeting Lentivector Vaccine to HIV-1 Gag by PD-1 Blockade